GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Privia Health Group Inc (NAS:PRVA) » Definitions » Debt-to-EBITDA

Privia Health Group (Privia Health Group) Debt-to-EBITDA : 0.71 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Privia Health Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Privia Health Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $3 Mil. Privia Health Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $5 Mil. Privia Health Group's annualized EBITDA for the quarter that ended in Mar. 2024 was $11 Mil. Privia Health Group's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.71.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Privia Health Group's Debt-to-EBITDA or its related term are showing as below:

PRVA' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.79   Med: 0.31   Max: 2.46
Current: 0.35

During the past 6 years, the highest Debt-to-EBITDA Ratio of Privia Health Group was 2.46. The lowest was -0.79. And the median was 0.31.

PRVA's Debt-to-EBITDA is ranked better than
84.51% of 426 companies
in the Healthcare Providers & Services industry
Industry Median: 2.555 vs PRVA: 0.35

Privia Health Group Debt-to-EBITDA Historical Data

The historical data trend for Privia Health Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Privia Health Group Debt-to-EBITDA Chart

Privia Health Group Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial 2.46 1.24 -0.22 -0.79 0.31

Privia Health Group Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.28 0.31 0.65 0.71

Competitive Comparison of Privia Health Group's Debt-to-EBITDA

For the Health Information Services subindustry, Privia Health Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Privia Health Group's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Privia Health Group's Debt-to-EBITDA falls into.



Privia Health Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Privia Health Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.043 + 5.246) / 27.182
=0.30

Privia Health Group's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.861 + 4.651) / 10.576
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Privia Health Group  (NAS:PRVA) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Privia Health Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Privia Health Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Privia Health Group (Privia Health Group) Business Description

Traded in Other Exchanges
N/A
Address
950 N. Glebe Road, Suite 700, Arlington, VA, USA, 22203
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Executives
William M Sullivan director ONE PENN PLAZA, SUITE 5300, NY NY 10119
Thomas Bartrum officer: EVP, General Counsel 950 N. GLEBE RD., SUITE 700, ALEXANDRIA VA 22203
Pamela O Kimmet director 11207 ORANGE HIBISCUS LANE, PALM BEACH GARDENS FL 33418
David S Wichmann director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752
Parth Mehrotra officer: President and COO 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Adam Boehler director 1215 5TH AVE N,, NASHVILLE TN 37208
Matthew Shawn Morris director, officer: Chief Executive Officer 950 N. GLEBE ST., SUITE 700, ARLINGTON VA 22203
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Jeffrey Daniel Bernstein director 200 WEST STREET, NEW YORK NY 10282
Pamplona Capital Partners Iii, L.p. 10 percent owner 94 SOLARIS AVENUE, CAMANA BAY, P.O. BOX 1348, GRAND CAYMAN E9 KY1-1108
Mbd Advisors, L.l.c. 10 percent owner 200 WEST STREET, NEW YORK NY 10282
David Mountcastle officer: Chief Financial Officer 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Jeffrey B Butler director 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22101
David P King director PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Patricia Anne Maryland director 7342 HORIZON DRIVE, WEST PALM BEACH FL 33412

Privia Health Group (Privia Health Group) Headlines

From GuruFocus

Privia Health Announces Secondary Offering

By Value_Insider Value_Insider 11-15-2022

Privia Health Announces Leadership Succession

By sperokesalga sperokesalga 04-12-2023

Privia Health to Participate in the Piper Sandler Healthcare Conference

By Value_Insider Value_Insider 11-28-2022

Privia Health to Participate in Upcoming Investor Conferences

By sperokesalga sperokesalga 05-31-2023

Privia Health Announces Secondary Offering

By sperokesalga sperokesalga 05-04-2023

Privia Health Enters Delaware with Beebe Healthcare; Launches Ninth ACO

By Stock market mentor Stock market mentor 01-17-2023